XML 42 R44.htm IDEA: XBRL DOCUMENT v2.4.1.9
3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) (USD $)
9 Months Ended 12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Mar. 31, 2014
Mar. 31, 2013
Cash uninsured amount $ 2,275,000us-gaap_CashUninsuredAmount      
Potentially antidilutive shares excluded from EPS 2,205,525us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount 2,902,111us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount 2,861,492us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount 2,854,024us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Amortization of deferred offering costs 68,982us-gaap_AmortizationOfFinancingCosts 863us-gaap_AmortizationOfFinancingCosts 863us-gaap_AmortizationOfFinancingCosts 127,200us-gaap_AmortizationOfFinancingCosts
Sales Revenue, Net [Member]        
Concentration risk percentage 100.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
100.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
100.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
100.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_SalesRevenueNetMember
Accounts Receivable, Net [Member]        
Concentration risk percentage 100.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
100.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
100.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
100.00%us-gaap_ConcentrationRiskPercentage1
/ us-gaap_ConcentrationRiskByBenchmarkAxis
= us-gaap_AccountsReceivableMember
Exosome Sciences, Inc.        
Stock sold, shares issued 300,000us-gaap_StockIssuedDuringPeriodSharesNewIssues
/ dei_LegalEntityAxis
= aemd_ExosomeMember
300,000us-gaap_StockIssuedDuringPeriodSharesNewIssues
/ dei_LegalEntityAxis
= aemd_ExosomeMember
300,000us-gaap_StockIssuedDuringPeriodSharesNewIssues
/ dei_LegalEntityAxis
= aemd_ExosomeMember
 
Stock sold, amount $ 1,500,000us-gaap_StockIssuedDuringPeriodValueOther
/ dei_LegalEntityAxis
= aemd_ExosomeMember
$ 1,500,000us-gaap_StockIssuedDuringPeriodValueOther
/ dei_LegalEntityAxis
= aemd_ExosomeMember
$ 1,500,000us-gaap_StockIssuedDuringPeriodValueOther
/ dei_LegalEntityAxis
= aemd_ExosomeMember
 
Ownership percentage 80.00%us-gaap_VariableInterestEntityOwnershipPercentage
/ dei_LegalEntityAxis
= aemd_ExosomeMember
80.00%us-gaap_VariableInterestEntityOwnershipPercentage
/ dei_LegalEntityAxis
= aemd_ExosomeMember
80.00%us-gaap_VariableInterestEntityOwnershipPercentage
/ dei_LegalEntityAxis
= aemd_ExosomeMember
80.00%us-gaap_VariableInterestEntityOwnershipPercentage
/ dei_LegalEntityAxis
= aemd_ExosomeMember